Residency Programs: Infectious Diseases Pharmacy Residency (PGY-2)

The Infectious Diseases (PGY-2) specialty residency provides the resident with a robust experience in management of patients with infectious diseases across multiple different inpatient service lines including: infectious diseases consults, medical and surgical intensive care, cardiothoracic surgery, and emergency medicine. This goal of this program is for the resident to become well-versed in the multiple facets of infectious diseases, microbiology, and antimicrobial stewardship. The program is new and will be seeking accreditation by the American Society of Health-System Pharmacists.

As a member of the health care team, the resident assumes responsibility and accountability for safe and appropriate drug therapy and efficient delivery of care to patients. The resident is also involved in the academic, administrative, formulary management, and clinical drug research activities of the department.

Purpose and Goals

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced prac¬tice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

The Infectious Disease Pharmacy Practice Residency is an organized, directed postgraduate program that centers on developing a mastery of knowledge and an expert level of competency in infectious disease pharmacy practice. The goals of the UF Health Jacksonville PGY2 Infectious Diseases Residency Program are to develop the resident’s dedication and skills necessary to:

  • be a specialized practitioner with the confidence, competence and compassion necessary to provide complex medication recommendations that meets the needs of infectious disease patients
  • be a fully integrated member of the interdisciplinary team
  • provide safe, effective, and appropriate medication therapy to patients
  • effectively educate patients/family members, students and health care professionals regarding infectious disease medication issues
  • demonstrate leadership for infectious disease practice through participation in interdisciplinary committees and planning groups to improve care for patients
  • conduct research in the infectious diseases environment to improve medication use and pharmacy practice


Due to the active involvement of a highly skilled and motivated team of pharmacy practitioners with a variety of medical services, the resident is provided with a wide range of opportunities and experiences in the provision of patient care.

Program Structure

The residency program provides training in all aspects of infectious disease pharmacy practice. To accomplish this, newly onboarded residents will orient to the department of pharmacy and complete core, elective and longitudinal learning experiences which allow the resident enough flexibility to pursue their individual goals. Core and elective learning experiences are 4 or 8 weeks in duration. Longitudinal learning experiences are 52 weeks in duration.

  • Orientation (4 weeks if new to UF Health Jacksonville, 2 weeks concurrent if early commit)
  • Core Learning Experiences (7)
    • Antimicrobial Stewardship I (4 weeks)
    • Antimicrobial Stewardship II (4 weeks)
    • Infectious Diseases Consult Service I (8 weeks)
    • Infectious Diseases Consult Service II (8 weeks)
    • Medical Critical Care (4 weeks)
    • Microbiology (4 weeks)
    • Surgical/Trauma Critical Care (4 weeks)
  • Required Longitudinal Learning Experiences (4)
    • Infectious Diseases Continuity Clinic (½ day/week)
    • Infectious Diseases Practice
    • Practice Coverage (staffing) (Inpatient: 16 hours every 3rd weekend)
    • Research Project
  • Elective Learning Experiences (2)
    • Academia/Infectious Disease
    • Cardiothoracic Surgery
    • Emergency Medicine
    • Infectious Diseases Consult – Community
    • Transplant Infectious Diseases (4 weeks offsite)
      Other elective learning experiences may be developed based on resident interest and preceptor availability

Program Director

Christopher A Jankowski, Pharm.D., BCPS, BCIDP

Program Length

52 weeks, beginning in July


  • Stipend - $52,000
  • 27 days of leave
    • Personal leave - 7 days
    • Holidays - 5 days
    • Professional leave - ASHP Midyear meeting (3 days), Residency Research Conference (2 days), professional conference (5 days), interviews (5 days)
  • 6 research days
  • Health insurance
  • Dental coverage
  • Life insurance
  • Educational and professional travel allowances
  • Dedicated office space
  • Laptop

Application Requirements

Eligibility requirements for the residency program include the following:

  • Graduate from an ACPE-accredited college or school of pharmacy with a Doctor of Pharmacy degree
  • Completion of an ASHP-accredited Pharmacy (PGY-1) Residency
  • Eligible for licensure in the State of Florida – all residents must take their exams prior to the start of the residency
  • On-site interview
  • For non-resident alien applicants, authorization for employment that is valid through the residency period is required

Application Materials

  • Applicant information
  • Letter of intent
  • Current curriculum vitae
  • Letters of recommendation from three (3) professional sources
  • Official transcript of applicant’s pharmacy coursework and grades

The application deadline is January 5th.

Application materials should be submitted through PhORCAS.

Contact Information

Residency Coordinator
UF Health Jacksonville
Department of Pharmacy
655 West 8th Street, C-89
Jacksonville, FL 32209

Phone: (904) 244-4157
Fax: (904) 244-4272

After the application is complete and reviewed, the residency selection committee will notify selected applicants to arrange an onsite interview.